Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Phase I/II Study of Chemoradiation With Oxaliplatin and 5FU for Locally Advanced Pancreatic Cancer

NCT00463840 is registered in ClinicalTrials.gov with NYU Langone Health as lead sponsor.

NCT NCT00463840
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00463840 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Phase I/II Study of Chemoradiation With Oxaliplatin and 5FU for Locally Advanced Pancreatic Cancer
Lead sponsor
NYU Langone Health
Phase
Phase 1/2
Overall status
Terminated
Start date
June 30, 2004
Completion date
October 31, 2015
Enrollment
24 (actual)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

pancreatic cancer